CORPORATE GOVERNANCE

 I.  Institutional Matters

1. PPPI Legal Basis
   1. SEC Certificate of Filing of Amended Articles of Incorporation (change of name and amending the primary and secondary purpose of the corporation)
   2. SEC Certificate of Amended By-Laws issued on 09 November 2005
   3. SEC Certificate of Filing of Amended Articles of Incorporation (increase in capitalization)
   4. SEC Certificate of Increase of Capital Stocks
   5. SEC Certificate of Filing of Amended Articles of Incorporation (change of name and amending the primary purpose of the corporation)
   6. SEC Certificate of Amended By-Laws issued on 26 November 2015
   7. Executive Order No. 649-A – transferring PPI to DOH from OP
   8. Executive Order No. 54 – transferring PPI to DTI from DOH

2. Company background and SEC General Information Sheet
   1. 2022
   2. 2021
   3. 2016
   4. 2015
   5. 2014
   6. 2013

3. Parent Company and Affiliate

The Philippine Pharma Procurement, Inc. is a subsidiary of the Philippine International Trading Corporation and an affiliate of the National Development Company.

4. Government Corporate Information Sheet (GCIS), as mandated by the GCG in its Memorandum Circular No. 2012 – 01
   1. 2016
   2. 2015
   3. 2014
   4. 2013

II. On the Board and Officers

1. Complete List of Directors and Officers
   1. Governing Board
   2. Corporate Officers
   3. Key Officers

2. The Complete compensation package of all board members and officers, including travel, representation and any other form of expenses of allowances
   1. 2021 ROSA
   2. 2020 ROSA
   3. 2019 ROSA
   4. 2018 ROSA
   5. 2017 ROSA
   6. 2016 ROSA
   7. 2015 ROSA

3. Information on Board Committees

4. Attendance Record of Directors in Board Meetings
   1. 2021
   2. 2020
   3. 2019 
   4. 2018
   5. 2017
   6. 2016

III. On Financial and Operational Matters

1. Annual Audit Reports (AARs)
   1. 2022
   2. 2021
   3. 2020
   4. 2019
   5. 2018
   6. 2017
   7. 2016
   8. 2015
   9. 2014
   10. 2013
2. Quarterly Financial Reports and Trial Balance
   1. 1^st Quarter 2022  Financial Reports and Trial Balance
   2. 2^nd Quarter 2022  Financial Reports and Trial Balance
   3. 3^rd Quarter 2022 Financial Reports and Trial Balance
   4. 4^th Quarter 2022 Financial Reports and Trial Balance

3. Board Approved Corporate Operating Budget
   1. 2022
   2. 2021
   3. 2020
   4. 2019
   5. 2018
   6. 2017
   7. 2016
   8. 2015
   9. 2014

4. Local and Foreign Borrowing(Not Applicable)
5. Government Subsidies and Net Lending(Not Applicable)
6. Borrowing Guaranteed by the Government(Not Applicable)
7. Material Risk Factors and Measures to Manage Such Risk
8. Performance Evaluation System

IV. On Governance Matters

1. Charter Statement
2. Strategy Map and Performance Scorecard
3. Organizational Chart
4. Manual of Corporate Governance
5. Corporate Social Responsibility statement
6. Balanced Scorecard
7. No Gift Policy
8. Whistleblowing Policy
9. Code of Conduct for PPPI Officers and Employees
10. Statement of No Audit Suspension
    1. 2022
       • 1Q
       • 2Q
    2. 2021
       • 2Q
       • 4Q
    3. 2020
       • 1Q
       • 2Q
       • 3Q
       • 4Q
    4. 2019
       • 2Q
       • 3Q
       • 4Q
    5. 2018
       • 1Q
       • 2Q
       • 3Q
    6. 2017
       • 1Q
       • 2Q
       • 3Q
       • 4Q

        j. Agency Action Plan and Status of Implementation on COA AOM

1. 2021
2. 2017
3. 2015

       h.Freedom of Information Manual

       k. Corporate Social Responsibility

a.  Employees’ Welfare and Development

1. Training and Development Program
   1. 2022
   2. 2017
   3. 2016
   4. 2015
2. List of Training Conducted
   1. 2022
   2. 2017
   3. 2016
   4. 2015
3. GAD Plan
   1. 2023
   2. 2022